Psoriatic disease treatment nowadays: unmet needs among the "jungle of biologic drugs and small molecules"
- 1 July 2018
- journal article
- editorial
- Published by Springer Science and Business Media LLC in Clinical Rheumatology
- Vol. 37 (7), 1739-1741
- https://doi.org/10.1007/s10067-018-4090-6
Abstract
No abstract availableThis publication has 30 references indexed in Scilit:
- Vascular perfusion kinetics by contrast-enhanced ultrasound are related to synovial microvascularity in the joints of psoriatic arthritisClinical Rheumatology, 2015
- Pharmacogenomics and the Resulting Impact on Psoriasis TherapiesDermatologic Clinics, 2015
- Efficacy and safety of itolizumab, a novel anti-CD6 monoclonal antibody, in patients with moderate to severe chronic plaque psoriasis: Results of a double-blind, randomized, placebo-controlled, phase-III studyJournal of the American Academy of Dermatology, 2014
- Psoriasis: to treat or to manage?Experimental Dermatology, 2014
- JAK/STAT/PKCδ molecular pathways in synovial fluid T lymphocytes reflect the in vivo T helper-17 expansion in psoriatic arthritisImmunologic Research, 2014
- Effects of adalimumab therapy in adult subjects with moderate‐to‐severe psoriasis on Th17 pathwayJournal of the European Academy of Dermatology and Venereology, 2013
- Impact of 24-month treatment with etanercept, adalimumab, or methotrexate on metabolic syndrome components in a cohort of 210 psoriatic arthritis patientsClinical Rheumatology, 2013
- Oral apremilast in the treatment of active psoriatic arthritis: Results of a multicenter, randomized, double‐blind, placebo‐controlled studyArthritis & Rheumatism, 2012
- Psoriatic arthritis is associated with increased arterial stiffness in the absence of known cardiovascular risk factors: a case control studyClinical Rheumatology, 2011
- Cyclic nucleotide phosphodiesterases and their role in immunomodulatory responses: Advances in the development of specific phosphodiesterase inhibitorsMedicinal Research Reviews, 2004